CTJHF yields 4.65% · JNJ yields 2.13%● Live data
📍 CTJHF pulled ahead of the other in Year 1
Combined, CTJHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTJHF + JNJ for your $10,000?
CITIC Resources Holdings Limited, an investment holding company, engages in the exploration, development, and production of oil and coal. The company operates through four segments: Aluminum Smelting, Coal, Import and Export of Commodities, and Crude Oil. The Aluminum smelting segment operates a Portland aluminum smelter, which sources alumina and produces aluminum ingots in Australia. The Coal segment mines and sells coal in Australia. The Import and Export of Commodities segment exports various commodity products, such as aluminum ingots, alumina, and copper; and imports other commodities and manufactured goods, including steel, vehicle and industrial batteries, and tyres in Australia. The Crude Oil segment explores, develops, and operates oilfields, as well as sells oil in Indonesia and China. It also engages in financing; oil technology development; and property holding activities, as well as provides consulting and management services. The company was incorporated in 1997 and is headquartered in Kowloon, Hong Kong. CITIC Resources Holdings Limited is a subsidiary of CITIC Group Corporation.
Full CTJHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.